Literature DB >> 23010732

Effect of prophylactic central compartment neck dissection on serum thyroglobulin and recommendations for adjuvant radioactive iodine in patients with differentiated thyroid cancer.

Tracy S Wang1, Douglas B Evans, Gilbert G Fareau, Ty Carroll, Tina W Yen.   

Abstract

BACKGROUND: Controversy exists in the management of patients with differentiated thyroid cancer (DTC). The purpose of this study was to examine the effect of prophylactic central compartment neck dissection (CCND) on serum thyroglobulin (Tg) levels and recommendations for adjuvant radioactive iodine (RAI).
METHODS: The records of 103 patients who underwent completion/total thyroidectomy for DTC between January 2009 and November 2010 were reviewed. Prophylactic CCND was defined as removal of central compartment lymph nodes with no preoperative or intraoperative evidence of lymphadenopathy. Institutional protocol included a diagnostic whole-body scan before RAI; patients with a negative scan and Tg < 2.0 did not receive adjuvant RAI.
RESULTS: Among the 103 patients, therapeutic CCND was performed in 17 (17 %) and prophylactic CCND in 49 (48 %). Of the 49 patients, 20 (41 %) had positive cervical lymph nodes. Positive lymph nodes changed American Joint Committee on Cancer tumor, node, metastasis staging in 17 patients and recommendations for RAI in 14. At a median follow-up of 21 months, there was no difference in Tg level based on the application of CCND; however, 92 % of patients with M0 disease had an undetectable Tg. One patient had recurrent DTC based on serum Tg only.
CONCLUSIONS: Prophylactic CCND resulted in detection of unsuspected metastatic lymphadenopathy in 20 (41 %) of 49 patients and changed RAI recommendations in 14 (33 %). To date, most patients have an undetectable Tg. Longer follow-up is needed to detect potential differences in recurrent disease based on the use of CCND or long-term effects of RAI.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23010732     DOI: 10.1245/s10434-012-2594-x

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  24 in total

Review 1.  Controversies in the Management of Low-Risk Differentiated Thyroid Cancer.

Authors:  Megan R Haymart; Nazanene H Esfandiari; Michael T Stang; Julia Ann Sosa
Journal:  Endocr Rev       Date:  2017-08-01       Impact factor: 19.871

Review 2.  Prophylactic central neck disection in papillary thyroid cancer: a consensus report of the European Society of Endocrine Surgeons (ESES).

Authors:  Juan J Sancho; Thomas W Jay Lennard; Ivan Paunovic; Frédéric Triponez; Antonio Sitges-Serra
Journal:  Langenbecks Arch Surg       Date:  2013-12-19       Impact factor: 3.445

Review 3.  Impact of prophylactic central neck dissection on oncologic outcomes of papillary thyroid carcinoma: a review.

Authors:  Elisabeth Mamelle; Isabelle Borget; Sophie Leboulleux; Haïtham Mirghani; Carlos Suárez; Phillip K Pellitteri; Ashok R Shaha; Marc Hamoir; K Thomas Robbins; Avi Khafif; Juan P Rodrigo; Carl E Silver; Alessandra Rinaldo; Alfio Ferlito; Dana M Hartl
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-06-11       Impact factor: 2.503

4.  Pathologic features of metastatic lymph nodes identified from prophylactic central neck dissection in patients with papillary thyroid carcinoma.

Authors:  Hyoung Shin Lee; Chanwoo Park; Sung Won Kim; Woong Jae Noh; Soo Jin Lim; Bong Kwon Chun; Beom Su Kim; Jong Chul Hong; Kang Dae Lee
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-01-12       Impact factor: 2.503

Review 5.  2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer.

Authors:  Bryan R Haugen; Erik K Alexander; Keith C Bible; Gerard M Doherty; Susan J Mandel; Yuri E Nikiforov; Furio Pacini; Gregory W Randolph; Anna M Sawka; Martin Schlumberger; Kathryn G Schuff; Steven I Sherman; Julie Ann Sosa; David L Steward; R Michael Tuttle; Leonard Wartofsky
Journal:  Thyroid       Date:  2016-01       Impact factor: 6.568

Review 6.  Morbidity of central neck dissection for papillary thyroid cancer.

Authors:  Davide Lombardi; Remo Accorona; Alberto Paderno; Carlo Cappelli; Piero Nicolai
Journal:  Gland Surg       Date:  2017-10

7.  The need of prophylactic central lymph node dissection is controversial in terms of postoperative thyroglobulin follow-up of patients with cN0 papillary thyroid cancer.

Authors:  Mehmet Hakan Korkmaz; Bülent Öcal; Güleser Saylam; Erman Çakal; Ömer Bayır; Esra Tutal; Emel Çadallı Tatar
Journal:  Langenbecks Arch Surg       Date:  2017-02-21       Impact factor: 3.445

Review 8.  The pros and cons of routine central compartment neck dissection for clinically nodal negative (cN0) papillary thyroid cancer.

Authors:  Ai Chen Chan; Brian Hung Hin Lang; Kai Pun Wong
Journal:  Gland Surg       Date:  2013-11

9.  Prophylactic central neck dissection increases the cost of thyroid cancer care.

Authors:  Dawn M Elfenbein; Rebecca S Sippel
Journal:  Ann Surg Oncol       Date:  2013-10-08       Impact factor: 5.344

10.  Central Compartment Nodal Bulk: A Predictor of Permanent Postoperative Hypocalcaemia.

Authors:  S R Priya; Chandrashekhar Dravid
Journal:  Indian J Surg Oncol       Date:  2019-11-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.